Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

SS Pharm. discloses antitumor platinum complexes

Aug. 16, 1996

NCI supports clinical testing of MGI-114

Aug. 16, 1996

NCI begins pediatric study of carboplatin/RMP-7 combination

Aug. 16, 1996

FDA approves new formulation of Gensi Laboratories' etoposide

Aug. 9, 1996

Water-soluble prodrug of pancratistatin synthesized by Arizona State University

Aug. 9, 1996

Mylan to market generic Taxol in 3 countries

Aug. 9, 1996

RPR seeks approval of Campto in 13 European countries

Aug. 9, 1996

Aryl-ureido anticancer agents reported by Universite Laval

Aug. 9, 1996

Ethyol available on Canadian market

July 26, 1996

TPO711: Thrombopoietin useful as bone marrow cell proliferation therapy

July 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....